Major Depression Clinical Trial
Official title:
Cognitive Behavioral Treatments for Depression in Patients With Chronic Illness
Duke University Medical Center in collaboration with Glendale Adventist Medical Center
propose a randomized clinical trial of conventional cognitive behavior therapy (CCBT) vs.
religious cognitive behavior therapy (RCBT) for major depression in medical patients with
chronic disabling illness. Therapists will deliver the treatment in real time over the
Internet and/or by telephone to increase treatment access. This planning grant seeks support
for a two-site study (North Carolina and California) that consists of two phases. In Phase I
(Rounsaville 1a) the investigators will conduct an open trial of 30 patients to assess
subject recruitment, refine RCBT and CCBT manuals and protocol, assess compliance with
treatment, acceptability of treatment and delivery system (online vs. telephone), and allow
therapists gain experience with delivery system and RCBT.
In Phase II (Rounsaville 1b) the investigators will conduct a randomized proof of concept
comparison of CCBT vs. RCBT that will demonstrate feasibility and confirm the expected
clinically meaningful difference for a definitive R01 application. In Phase II, 70 religious
patients ages 18-85 with a new episode of major depression (MINI), scores of 16-35 on the
Beck Depression Inventory (BDI), and at least one chronic disabling medical illness will be
randomized to either CCBT or RCBT. The trial will consist of ten 50 min sessions
administered by master's level therapists and delivered over 12 weeks. The primary endpoint
will be BDI score at baseline, 4, 8, 12, and 24-week follow-up. Christian, Jewish, Hindu,
Buddhist, and Muslim versions of the RCBT manual will be developed, and CBT experts in each
of these traditions will supervise therapists delivering the intervention to patients from
these faith traditions.
The purpose of this study is to determine feasibility and effect sizes for a future, fully
powered treatment study. The importance is that results will be relevant to therapists well
beyond those who explicitly practice pastoral counseling, extending to many secular
therapists as well. If 65% of Americans indicate that religion is an important part of daily
life and the vast majority of chronically ill medical patients wish to include it in their
therapy, then all therapists (whether they have explicit training in pastoral counseling or
not) are likely to encounter patients in which this approach would be applicable.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03062150 -
Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression
|
N/A | |
Completed |
NCT04352101 -
Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
|
Phase 4 | |
Completed |
NCT02855918 -
Blood Biomarkers in Suicidal Behaviour
|
N/A | |
Recruiting |
NCT03039387 -
Effects of tDCS on Cognitive Control and Emotion Regulation in Depressed Patients
|
N/A | |
Recruiting |
NCT02213016 -
Effectiveness of Repetitive Transcranial Magnetic Stimulation in Depressed Patients
|
Phase 4 | |
Completed |
NCT01683539 -
Understanding How Cognitive Remediation Works
|
N/A | |
Completed |
NCT01636791 -
CBT Versus a Return to Work Intervention for Patients With Common Mental Illness in Primary Care
|
Phase 3 | |
Recruiting |
NCT02237937 -
Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene
|
Phase 4 | |
Completed |
NCT01201148 -
Open Pilot Trial of TES for Depression
|
Phase 2 | |
Completed |
NCT00953108 -
Quetiapine Prolong, Escitalopram and Hypothalamic-pituitary-adrenocortical (HPA) Axis Activity in Depressed Patients
|
Phase 3 | |
Terminated |
NCT01244711 -
Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines
|
Phase 4 | |
Completed |
NCT00806143 -
Bilateral Versus Monolateral Repetitive Transcranial Stimulation in Depression
|
Phase 4 | |
Terminated |
NCT00695552 -
The Effect of Exercise on Depressive Symptoms in Unmedicated Patients
|
N/A | |
Completed |
NCT00711737 -
Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months
|
N/A | |
Completed |
NCT00482482 -
Yoga in Unipolar and Bipolar Disorders
|
N/A | |
Completed |
NCT00466323 -
The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness.
|
N/A | |
Completed |
NCT00532480 -
Study of Brain Response to Emotional Pictures Using a fMRI While on Duloxetine
|
Phase 4 | |
Completed |
NCT00616759 -
The Effect on Cognition of Terminating ECT Induced Seizures With Propofol
|
N/A | |
Recruiting |
NCT00209807 -
Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder
|
Phase 4 | |
Completed |
NCT00149110 -
Chronos: the Use of Chronobiological Treatment in Depression
|
N/A |